Search

Author/Creator Cavalli, M.

2. Ficoll‐hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis. (4th December 2017)

Authors:
Genuardi, E.; Barbero, D.; Dogliotti, I.; Mantoan, B.; Drandi, D.; Gambella, M.; Zaccaria, G. M.; Monitillo, L.; Della Starza, I.; Cavalli, M.; De Novi, L. A.; Ciabatti, E.; Grassi, S.; Gazzola, A.; Mannu, C.; Del Giudice, I.; Galimberti, S.; Agostinelli, C.; Piccaluga, P. P.; Ladetto, M.
Journal:
International journal of laboratory hematology
Issue:
Volume 40:Number 2(2018:Apr.)
Page Start:
201
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy. (March 2015)

Authors:
Viale, P.; Tumietto, F.; Giannella, M.; Bartoletti, M.; Tedeschi, S.; Ambretti, S.; Cristini, F.; Gibertoni, C.; Venturi, S.; Cavalli, M.; De Palma, A.; Puggioli, M.C.; Mosci, D.; Callea, E.; Masina, R.; Moro, M.L.; Lewis, R.E.
Journal:
Clinical microbiology and infection
Issue:
Volume 21:Number 3(2015:Mar.)
Page Start:
242
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. MINIMAL RESIDUAL DISEASE (MRD) IN EARLY STAGE FOLLICULAR LYMPHOMA CAN PREDICT PROGNOSIS AND DRIVE RITUXIMAB TREATMENT AFTER RADIOTHERAPY. (June 2017)

Authors:
Pulsoni, A.; Della Starza, I.; Cappelli, L.V.; Tosti, M.E.; Annechini, G.; Cavalli, M.; De Novi, L.A.; D'Elia, G.M.; Grapulin, L.; Guarini, A.; Del Giudice, I.; Foa', R.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
223
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. UPDATED RESULTS OF THE FIL "MIRO" STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA. (17th June 2021)

Authors:
Pulsoni, A.; Tosti, M. E.; Ferrero, S.; Luminari, S.; Dondi, A.; Liberati, A. M.; Cenfra, N.; Renzi, D.; Zanni, M.; Boccomini, C.; Ferreri, A. J.; Rattotti, S.; Zilioli, V. R.; Bernuzzi, P.; Bolis, S.; Musuraca, G.; Nassi, L.; Perrone, T.; Stelitano, C.; Anastasia, A.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. UPDATED RESULTS OF THE FIL "MIRO" STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA. (17th June 2021)

Authors:
Pulsoni, A.; Tosti, M. E.; Ferrero, S.; Luminari, S.; Dondi, A.; Liberati, A. M.; Cenfra, N.; Renzi, D.; Zanni, M.; Boccomini, C.; Ferreri, A. J.; Rattotti, S.; Zilioli, V. R.; Bernuzzi, P.; Bolis, S.; Musuraca, G.; Nassi, L.; Perrone, T.; Stelitano, C.; Anastasia, A.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗